Hospitals not neutral on ‘site-neutral’

Medicare’s site-neutral policy, which pays outpatient hospital sites like they’re independent doctors’ offices, is turning out to be as unpopular in practice as it was in theory—as least among hospitals.

A piece produced by Kaiser Health News and picked up by NPR looks into the cloud of discontent and finds names, faces and real-world consequences.

For example, the CEO of a 126-bed hospital in rural Washington State says the payment cuts have forced his organization to shelve its plans to build a primary-care clinic that would have served many patients close to where they live.

“If you’re well-to-do financially, these aren’t big problems,” said the executive, Eric Lewis of Olympic Medical Center. “But I think the poorest, elderly, sickest of our society will pay the price of this policy.”

Lewis anticipates a loss of $1.6 million for his hospital.

Of course, there are two sides to the story. Reporter Carmen Heredia Rodriguez points out that the change will save patients an average of $7 each time they visit a hospital-owned clinic. Plus CMS estimates site-neutral payments will save the agency $380 million this year alone.

Still, some hospital leaders and advocates remain unconvinced the tradeoff is worth the trouble, especially to patients.

“I think access trumps a couple extra dollars in copays every single time,” said Melinda Hatton, general counsel for the AHA.

Get the rest of the story:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup